All Sauce from Weekly Sauce:

Emergency medicine doctors someday might rely on consultation from artificial intelligence (AI) programs like ChatGPT to help them quickly and accurately diagnose patients’ ailments. A new study found that ChatGPT performed about as well as human doctors in diagnosing patients, when both are given the same set of clinical information. “In the end, they were…  read on >  read on >

Before pouring another drink, consider this sobering new research: Heavy drinkers can develop fat around the heart, leading to heart failure and other cardiac problems. This so-called pericardial fat is associated with increased risk of heart disease. Researchers also linked heavy drinking to excess fat deposits around the liver and kidneys, which can result in…  read on >  read on >

Whole-body MRI scans are the latest health fad to be promoted by celebrities, with Kim Kardashian taking to Instagram last month to tout the practice. But doctors are warning that such whole-body scans, while tempting, are pricey and not all that accurate. In fact, the average person is more likely to be unnecessarily harmed by…  read on >  read on >

Over 3 million American children now take medication for attention-deficit/hyperactivity disorder (ADHD), but new research shows medication errors have spiked nearly 300% in the past two decades for these kids. The increase in ADHD medication errors parallels the increase in ADHD diagnoses, said study co-author Dr. Gary Smith, director of the Center for Injury Research…  read on >  read on >

As people age, health issues tend to mount, but roughly a quarter of low-income adults over 65 have no medical insurance. That’s the age when most Americans become eligible for Medicare, the federal health insurance for seniors. But many of the uninsured seniors are Hispanic Americans who aren’t eligible for that coverage, or lower income…  read on >  read on >

A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms. The study, led by Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University, found no symptom improvement in those taking the antidepressant at a dose of…  read on >  read on >